Skip to content

Federal Contractor Profile

Iit Research Institute

$56M obligated·101 awards·2 agencies·12 NAICS

Federal Contracts

Showing award actions 51–100 of 141 funded award actions, most recent first.

Contracts with positive obligations
101
Funded award actions shown
141
Obligations shown
$56M
Awarding agencies
2

This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.

Award data as of September 28, 2026. Source: USAspending federal award records.

DateAgencyPIIDNAICSDescriptionAmount
Apr 26, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00002541712TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2022.$207K
Mar 29, 2022Department of Health and Human ServicesNIH NCI75N91022C00010541715PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS$75K
Mar 28, 2022Department of Health and Human ServicesNIH NCI75N91020F00001541714PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF PROSTATE CANCER$291K
Feb 14, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00003541712NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO). POP: 09/25/2020 TO 03/24/2021.$10K
Dec 10, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93022F00001541714PRECLINICAL MICROBIOLOGICAL, SAFETY, TOXICOLOGY, AND PHARMACOKINETIC SERVICES$1.9M
Dec 3, 2021Department of Health and Human ServicesNIH NCI75N91020F00001541714TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION PERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022$34K
Sep 30, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95021F00001541715CONTRACT KICK-OFF MEETING FOR NINDS PHARMACOLOGY AND TOXICOLOGY FOR THERAPEUTICS PROGRAM (PTTP)$11
Sep 29, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95021F00001541715CONTRACT KICK-OFF MEETING FOR NINDS PHARMACOLOGY AND TOXICOLOGY FOR THERAPEUTICS PROGRAM (PTTP)$2K
Sep 7, 2021Department of Health and Human ServicesNIH NCI75N91018F00005541711IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXERCISED)$702K
Aug 23, 2021Department of Health and Human ServicesNIH NCI75N91021F00001541714EVALUATION OF AFPEP FOR THE PREVENTION OF BREAST CANCER$535K
Jul 19, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00001541712NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020.$1.3M
Jun 23, 2021Department of Health and Human ServicesNIH NCI75N91018F00005541711IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXERCISED)$25K
Apr 27, 2021Department of Health and Human ServicesNIH NCI75N91018F00005541711IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXERCISED)$118K
Feb 26, 2021Department of Health and Human ServicesNIH NCIHHSN26100003541690IGF::OT::IGF NEXT PRECLINICAL TOXICOLOGY&PHARMACOLOGY OF DRUGS DEVELOPED FOR CANCER PATIENTS, TO#3, EXPLORATORY STUDIES OF CCR4 CART CELLS$239K
Feb 11, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00001541712NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020.$530K
Nov 30, 2020Department of DefenseW6QK ACC-APG NATICKW911QY21C0014541380TECHNLOLOGY TRANSFER ASSAYS$981K
Sep 24, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00003541712NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO). POP: 09/25/2020 TO 03/24/2021.$324K
Sep 21, 2020Department of Health and Human ServicesNIH NCI75N91020F00001541690SUPPORT FOR THE PRECLINICAL DEVELOPMENT OF EIF4A INHIBITORS ROCAGLAMIDE AND DIDESMETHYLROCAGLAMIDE. (TOXICIOLOGY SERVICES TO SUPPORT PRECLINICAL DRUG DEVELOPMENT) POP 09/23/2020-09/22/2021.$589K
Sep 16, 2020Department of Health and Human ServicesNIH NCI75N91020F00002541714COVID-19 RELATED STUDY INVOLVING DOGS$598K
Sep 16, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00002541712TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2022.$1.8M
Sep 15, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00001541712NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020.$153K
Sep 14, 2020Department of Health and Human ServicesNIH NCI75N91020F00001541714TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION PERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022$213K
Sep 2, 2020Department of Health and Human ServicesNIH NCI75N91020F00001541714PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF PROSTATE CANCER$430K
Aug 27, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95019F00091541712NON-CLINICAL SAFETY ASSESSMENT OF ACOZIBOROLE (SCYX-7158) TO SUPPORT HUMAN AFRICAN TRYPANOSOMIASIS (HAT OR "SLEEPING SICKNESS"). POP: 09/01/2019 TO 08/31/2020.$7K
Aug 26, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDAHHSN27100001541712IGF::OT::IGF TASK ORDER AWARD FOR "NON-CLINICAL SAFETY ASSESSMENT OF SPIF TO SUPPORT CHRONIC GVHD INDICATION" TO IIT RESEARCH INSTITUTE$95K
Jul 17, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95019F00091541712NON-CLINICAL SAFETY ASSESSMENT OF ACOZIBOROLE (SCYX-7158) TO SUPPORT HUMAN AFRICAN TRYPANOSOMIASIS (HAT OR "SLEEPING SICKNESS"). POP: 09/01/2019 TO 08/31/2020.$81K
Jun 3, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95019F00090541712GLP 28 DAY TOXICITY STUDY OF ACT-1 WHEN APPLIED TOPICALLY TO EYES TWICE DAILY FOR 28 DAYS IN DOGS WITH A 14 DAY RECOVERY PERIOD. POP: 09/01/2019 TO 02/29/2020.$85K
Apr 14, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50118F33001541711IGF::OT::IGF$637K
Mar 3, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMAHHSO10033002T325414IGF::OT::IGF$84K
Feb 25, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95019F00090541712GLP 28 DAY TOXICITY STUDY OF ACT-1 WHEN APPLIED TOPICALLY TO EYES TWICE DAILY FOR 28 DAYS IN DOGS WITH A 14 DAY RECOVERY PERIOD. POP: 09/01/2019 TO 02/29/2020.$24K
Aug 27, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95019F00090541712GLP 28 DAY TOXICITY STUDY OF ACT-1 WHEN APPLIED TOPICALLY TO EYES TWICE DAILY FOR 28 DAYS IN DOGS WITH A 14 DAY RECOVERY PERIOD. POP: 09/01/2019 TO 02/29/2020.$441K
Aug 26, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95019F00091541712NON-CLINICAL SAFETY ASSESSMENT OF ACOZIBOROLE (SCYX-7158) TO SUPPORT HUMAN AFRICAN TRYPANOSOMIASIS (HAT OR "SLEEPING SICKNESS"). POP: 09/01/2019 TO 08/31/2020.$1.1M
Aug 6, 2019Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50118F33002541711IGF::OT::IGF$726K
Mar 29, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDAHHSN27100001541712IGF::OT::IGF TASK ORDER AWARD FOR "NON-CLINICAL SAFETY ASSESSMENT OF SPIF TO SUPPORT CHRONIC GVHD INDICATION" TO IIT RESEARCH INSTITUTE$194K
Mar 21, 2019Department of Health and Human ServicesNIH NCI75N91018F00004541690THREE RABBIT STUDY: (1) DOSE RANGE FINDING STUDY IN RABBITS VIA ORAL GAVAGE (NON-GLP); (2) PRELIMINARY EMBRYO FETAL DEVELOPMENTAL STUDY IN RABBITS VIA ORAL GAVAGE (NON-GLP); (3) EMBRYO FETAL DEVELOPMENTAL STUDY IN NEW ZEALAND WHITE RABBITS VIA ORAL GAVAGE (GLP))$52K
Mar 4, 2019Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50118F33001541711IGF::OT::IGF$122K
Jan 25, 2019Department of Health and Human ServicesNIH NCIHHSN26100004541711IGF::OT::IGF SUPPORT FOR THE AEROSOL DEVELOPMENT OF BEXAROTENE HHSN2612015000240 TO: HHSN26100004 POP: 9/18/2017 TO 9/17/2019$57K
Jan 23, 2019Department of Health and Human ServicesNIH NCI75N91019F00129541714"CONTRACT ORIENTATION AND KICKOFF MEETING", TASK ORDER #1 UNDER 75N91019D00012. TASK ORDER PERIOD OF PERFORMANCE: 1/25/2019-2/24/2019.$4K
Jan 23, 2019Department of Health and Human ServicesNIH NCI75N91019F00129541714"CONTRACT ORIENTATION AND KICKOFF MEETING" UNDER CONTRACT 75N91019D00013$4K
Sep 25, 2018Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50118F33001541711IGF::OT::IGF$1.8M
Sep 24, 2018Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50118F33002541711IGF::OT::IGF$1.8M
Sep 14, 2018Department of Health and Human ServicesNIH NCI75N91018F00005541711IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXERCISED)$686K
Sep 11, 2018Department of Health and Human ServicesNIH NCI75N91018F00003541711PRECLINICAL EFFICACY EVALUATION OF THE LIPID-BASED SMEDDS FORMULATION OF DIM, BR-9001, TO AWARD 3$119K
Sep 5, 2018Department of Health and Human ServicesNIH NCI75N91018F00004541690THREE RABBIT STUDY: (1) DOSE RANGE FINDING STUDY IN RABBITS VIA ORAL GAVAGE (NON-GLP); (2) PRELIMINARY EMBRYO FETAL DEVELOPMENTAL STUDY IN RABBITS VIA ORAL GAVAGE (NON-GLP); (3) EMBRYO FETAL DEVELOPMENTAL STUDY IN NEW ZEALAND WHITE RABBITS VIA ORAL GAVAGE (GLP))$436K
Aug 30, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95018F00005541712NON-CLINICAL SAFETY ASSESSMENT OF BPN14770 TO SUPPORT PEDIATRIC POPULATION WITH FRAGILE X SYNDROME$902K
Aug 21, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95018F00004541712IIT RESEARCH INSTITUTE:1107221$1.2M
Aug 7, 2018Department of Health and Human ServicesNIH NCI75N91018F00003541711PRECLINICAL EFFICACY EVALUATION OF THE LIPID-BASED SMEDDS FORMULATION OF DIM, BR-9001, TO AWARD 3$855K
Jul 11, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95018F00003541712IIT RESCH INSTITUTE:1107221 [18-005715] TO PERFORM THE STUDY "SINGLE PO DOSE CARDIOVASCULAR AND PULMONARY SAFETY PHARMACOLOGY STUDY OF METARRESTIN IN TELEMETERED BEAGLE DOGS USING LATIN-SQUARE CROSS OVER STUDY DESIGN".$139K
Jun 26, 2018Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMAHHSO10033004T325414IGF::OT::IGF$44K
Jun 4, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93018F00001541714TO ISSUE TASK ORDER HHSN27200001, TASK AREA F, BASE IDIQ CONTRACT KICK-OFF$26K

Get Alerted Before Iit Research Institute's Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start for free